IONS position history
The shares of Ionis Pharmaceuticals (IONS) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 8,511,384 shares, $285M, 0.69% of portfolio
- 2021 Q4: 7,083,256 shares, $216M, 0.65% of portfolio, Reduce −16.8%
- 2022 Q1: 6,171,308 shares, $229M, 0.95% of portfolio, Reduce −12.9%
- 2022 Q2: 4,701,297 shares, $172M, 1.0% of portfolio, Reduce −23.8%
- 2022 Q3: 3,713,107 shares, $164M, 1.1% of portfolio, Reduce −21.0%
- 2022 Q4: 2,673,538 shares, $101M, 0.88% of portfolio, Reduce −28.0%
- 2023 Q1: 2,637,192 shares, $94M, 0.65% of portfolio, Reduce −1.4%
- 2023 Q2: 2,422,631 shares, $99M, 0.66% of portfolio, Reduce −8.1%
- 2023 Q3: 2,366,367 shares, $107M, 0.82% of portfolio, Reduce −2.3%
- 2023 Q4: 1,905,056 shares, $96M, 0.57% of portfolio, Reduce −19.5%
- 2024 Q1: 1,399,852 shares, $61M, 0.42% of portfolio, Reduce −26.5%
- 2024 Q2: 1,361,025 shares, $65M, 0.58% of portfolio, Reduce −2.8%
- 2024 Q3: 1,384,269 shares, $55M, 0.51% of portfolio, Add +1.7%
- 2024 Q4: 1,025,260 shares, $36M, 0.30% of portfolio, Reduce −25.9%
- 2025 Q1: 1,000,527 shares, $30M, 0.30% of portfolio, Reduce −2.4%
- 2025 Q2: 900,318 shares, $36M, 0.26% of portfolio, Reduce −10.0%
- 2025 Q3: 631,215 shares, $41M, 0.25% of portfolio, Reduce −29.9%
- 2025 Q4: 422,968 shares, $33M, 0.22% of portfolio, Reduce −33.0%
- 2026 Q1: 288,716 shares, $22M, 0.17% of portfolio, Reduce −31.7%
- 2026 Q2: 300,770 shares, $24M, 0.15% of portfolio, Add +4.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|